Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 43 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9193769

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  2. US 9186406

    Compositions containing nucleosides and manganese and their uses

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  3. US 9186365

    Antiangiogenic small molecules and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  4. US 9181253

    Adenosine receptor agonists, partial agonists, and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  5. US 9180179

    Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  6. US 9181340

    TEM8 antibodies, conjugates thereof, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  7. US 9181306

    Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  8. US 9181327

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  9. US 9180133

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  10. US 9181530

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  11. US 9175062

    Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  12. US 9175038

    Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  13. US 9173898

    Methods of treating giardiasis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  14. US 9175057

    Immunogenic peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  15. US 9175049

    Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  16. US 9173931

    Process for preparing polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  17. US 9175070

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  18. US 9169297

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  19. US 9168297

    Regulation of skin pigmentation by neuregulin-1 (NRG-1)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  20. US 9169296

    Expression and assembly of human group C rotavirus-like particles and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  21. US 9168291

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  22. US 9168266

    Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  23. US 9169182

    Chrysophaentin analogs that inhibit FtsZ protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  24. US 9163258

    Method for the treatment of obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.